Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Ignacio Cruz‐ Gonzalez"'
Autor:
Pablo Salinas, Luis Nombela-Franco, Ignacio Cruz-Gonzalez, Xavier Freixa, Enrico Cerrato, Patricia Simal, Pilar Jimenez-Quevedo, Jose Alberto de Agustín, Gabriela Tirado, Sergio García-Blas, Adrián Jerónimo, Guillermo Dueñas, Gabriela Veiga-Fernandez, Luis Renier Goncalves-Ramirez, Ana Fernández-Revuelta, Pedro Cepas-Guillén, Francesco Tomassini, Sergio Lopez-Tejero, Rafael Gonzalez-Manzanares, Jose M De la Torre Hernandez, Armando Perez de Prado, Ernesto Valero, Rami Gabani, Alejandro Travieso
Publikováno v:
Open Heart, Vol 11, Iss 2 (2024)
Background The benefit of patent foramen ovale closure (PFOC) ≤9 months after a cryptogenic stroke has been demonstrated in several randomised clinical trials. There is, however, insufficient data to support PFOC in non-recent cryptogenic strokes.A
Externí odkaz:
https://doaj.org/article/935aa5dc24c54b06a4cea1082084b610
Autor:
Jean C. Núñez García, Manuel Barreiro-Perez, Alejandro Diego-Nieto, Javier Martin-Moreiras, Jesus Herrero-Gabiri, Javier Rodriguez Collado, Pedro L. Sanchez, Ignacio Cruz-Gonzalez
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 42, Iss 2, Pp 173-175 (2023)
Externí odkaz:
https://doaj.org/article/67eb4cdfe9114555aeeb13185c3b3906
Publikováno v:
Mastering Structural Heart Disease. :425-432
Autor:
Adel Aminian, Ignacio Cruz-Gonzalez, Xavier Freixa, Ole de Backer, Lars Søndergaard, Xavier Iriart, Philippe Garot, Joelle Kefer, Sergio Berti, Liesbeth Rosseel, Reda Ibrahim, Kasper Korsholm, Jacob Odenstedt, Jens-Erik Nielsen-Kudsk, Jaqueline Saw
Publikováno v:
Open Heart, Vol 7, Iss 2 (2020)
Background Optimal preprocedural planning is essential to ensure successful device closure of the left atrial appendage (LAA).Design The PREDICT-LAA study is a prospective, international, multicentre, randomised controlled trial (ClinicalTrials.gov N
Externí odkaz:
https://doaj.org/article/884efc4ee6ee413a8050d56ba73a224e
Autor:
Alejandro Diego‐Nieto, Maria B. Vidriales, Norberto Alonso‐Orcajo, Jose C. Moreno‐Samos, Francisco Martin‐Herrero, Raul Carbonell, Belen Cid, Ignacio Cruz‐Gonzalez, Javier C. Martin‐Moreiras, Carlos Cuellas, Cristina Pascual, Maria Lopez‐Benito, Pedro L. Sanchez, Felipe Fernandez‐Vazquez, Armando Perez de Prado
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 19 (2018)
Background Ticagrelor use during acute coronary syndromes demonstrated a decrease in all‐cause mortality in the PLATO (Platelet Inhibition and Patient Outcomes) trial. This effect has been attributed to a non–platelet‐derived improvement in end
Externí odkaz:
https://doaj.org/article/f2b404cda6714a4d97a349f6ccf03977
Publikováno v:
JACC: Case Reports, Vol 1, Iss 5, Pp 703-704 (2019)
Externí odkaz:
https://doaj.org/article/017d4bc8039c436b8821aa8508babfee
Autor:
María González-Núñez, Adela S. Riolobos, Orlando Castellano, Isabel Fuentes-Calvo, María de los Ángeles Sevilla, Bárbara Oujo, Miguel Pericacho, Ignacio Cruz-Gonzalez, Fernando Pérez-Barriocanal, Peter ten Dijke, Jose M. López-Novoa
Publikováno v:
Disease Models & Mechanisms, Vol 8, Iss 11, Pp 1427-1439 (2015)
The activin receptor-like kinase 1 (ALK-1) is a type I cell-surface receptor for the transforming growth factor-β (TGF-β) family of proteins. Hypertension is related to TGF-β1, because increased TGF-β1 expression is correlated with an elevation i
Externí odkaz:
https://doaj.org/article/2eee324013bc416c91c1092aadad3ff4
Autor:
Jean C. Núñez García, Manuel Barreiro-Perez, Javier Martin-Moreiras, Pablo Antúnez-Muiños, Sergio López-Tejero, Alejandro Diego-Nieto, Javier Rodriguez Collado, Jesus Herrero-Gabiri, Pedro L. Sanchez, Ignacio Cruz-Gonzalez
Publikováno v:
JACC: Cardiovascular Interventions. 15:996-998
Autor:
Victoria Vilalta, Pablo Piñón, Juan García de Lara, Xavier Millán, Rafael Romaguera, Xavier Carrillo, Eduard Fernández-Nofrerías, Jose Montero-Cabezas, Victoria Delgado, Ignacio Cruz-Gonzalez, Antoni Bayés-Genís, Josep Rodés-Cabau
Publikováno v:
JACC. Cardiovascular interventions. 16(1)
Autor:
Mirjam G. Wild, Edith Lubos, Ignacio Cruz-Gonzalez, Ignacio Amat-Santos, Marco Ancona, Martin Andreas, Niklas F. Boeder, Christian Butter, Fernando Carrasco-Chinchilla, Rodrigo Estevez-Loureiro, Jörg Kempfert, Benedikt Köll, Matteo Montorfano, Holger M. Nef, Stefan Toggweiler, Axel Unbehaun, Paul Werner, Stephan Windecker, Fabien Praz
Publikováno v:
Circulation. Cardiovascular interventions. 15(3)
Background: Patients with severe tricuspid regurgitation present late and are often ineligible for surgery or transcatheter repair systems. Transfemoral venous implantation of a bicaval valved stent has been proposed as therapeutic option in selected